Gunn et al. GABAA receptors, neurosteroids, and stress understood. Signiﬁcant advances in this ﬁeld of research and the development of neurosteroid-based therapeutic strategies will require such mechanisms to be elucidated together with a better understanding of their sensitivity to environmental inﬂuences. ACKNOWLEDGMENTS Supported by the Wellbeing of Women (Grant number RG1265), Tenovus Scotland, AJ Clark Studentship, and the MRC (Grant 1000008). REFERENCES Agis-Balboa, R. C., Pinna, G., Zhubi, A., Maloku, E., Veldic, M., Costa, E., and Guidotti, A. (2006). Char- acterization of brain neurons that express enzymes mediating neuros- teroid biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 103, 14602–14607. Akk, G., Li, P., Bracamontes, J., Reichert, D. E., Covey, D. F., and Stein- bach, J. H. (2008). Mutations of the GABA-A receptor α1 subunitM1 domain reveal unexpected complex- ity for modulation by neuroac- tive steroids. Mol. Pharmacol. 74, 614–627. Akk, G., Shu, H. J., Wang, C., Steinbach, J. H., Zorumski, C. F., Covey, D. F., and Mennerick, S. (2005). Neuros- teroid access to the GABAA receptor. J. Neurosci. 25, 11605–11613. Alfarez, D. N., Joels, M., and Krugers, H. J. (2003). Chronic unpredictable stress impairs long-term potentia- tion in rat hippocampal CA1 area and dentate gyrus in vitro. Eur. J. Neurosci. 17, 1928–1934. Alfarez, D. N., Wiegert, O., Joels, M., and Krugers, H. J. (2002). Corticosterone and stress reduce synaptic potenti- ation in mouse hippocampal slices with mild stimulation. Neuroscience 115, 1119–1126. Avishai-Eliner, S., Eghbal-Ahmadi, M., Tabachnik, E., Brunson, K. L., and Baram, T. Z. (2001). Down-regulation of hypothalamic corticotropin-releasing hormone messenger ribonucleic acid (mRNA) precedes early-life experience- induced changes in hippocampal glucocorticoid receptor mRNA. Endocrinology 142, 89–97. Baghai, T. C., di Michele, F., Schule, C., Eser, D., Zwanzger, P., Pasini, A., Romeo, E., and Rupprecht, R. (2005). Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Neuropsychopharmacol- ogy 30, 1181–1186. Bajo, M., Cruz, M. T., Siggins, G. R., Messing, R., and Roberto, M. (2008). Protein kinase C epsilon media- tion of CRF- and ethanol-induced GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 105, 8410–8415. Bale, T. L., Baram, T. Z., Brown, A. S., Goldstein, J. M., Insel, T. R., McCarthy, M. M., Nemeroff, C. B., Reyes, T. M., Simerly, R. B., Susser, E. S., and Nestler, E. J. (2010). Early life programming and neurodevelopmental disorders. Biol. Psychiatry 68, 314–319. Bale, T. L., and Vale, W. W. (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44, 525–557. Bali, B., and Kovacs, K. J. (2003). GABAergic control of neuropep- tide gene expression in parvocellular neurons of the hypothalamic par- aventricular nucleus. Eur. J. Neu- rosci. 18, 1518–1526. Barbaccia, M. L., Roscetti, G., Trabuc- chi, M., Mostallino, M. C., Con- cas, A., Purdy, R. H., and Biggio, G. (1996). Time-dependent changes in rat brain neuroactive steroid con- centrations and GABAA receptor function after acute stress. Neuroen- docrinology 63, 166–172. Barbaccia, M. L., Serra, M., Purdy, R. H., and Biggio, G. (2001). Stress and neuroactive steroids. Int. Rev. Neurobiol. 46, 243–272. Barker, D. J. (2002). Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 13, 364–368. Barker, J. L., Harrison, N. L., Lange, G. D., and Owen, D. G. (1987). Poten- tiation of gamma-aminobutyric- acid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurones. J. Physiol. 386, 485–501. Batarseh, A., and Papadopoulos, V. (2010). Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol. Cell. Endocrinol. 327, 1–12. Belelli, D., Casula, A., Ling, A., and Lam- bert, J. J. (2002). The inﬂuence of subunit composition on the interac- tion of neurosteroids with GABAA receptors. Neuropharmacology 43, 651–661. Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., and Cope, D. W. (2009). Extrasynaptic GABAA receptors: form, pharma- cology, and function. J. Neurosci. 29, 12757–12763. Belelli, D., and Herd, M. B. (2003). The contraceptive agent Provera enhances GABAA receptor- mediated inhibitory neurotrans- mission in the rat hippocampus: evidence for endogenous neu- rosteroids? J. Neurosci. 23, 10013–10020. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regula- tors of the GABAA receptor. Nat. Rev. Neurosci. 6, 565–575. Bernardi, F., Lanzone, A., Cento, R. M., Spada, R. S., Pezzani, I., Genazzani, A. D., Luisi, S., Luisi, M., Petraglia, F., and Genazzani, A. R. (2000). Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer’s disease and vascular dementia. Eur. J. Endocrinol. 142, 466–471. Bianchi, M. T., and Macdonald, R. L. (2003). Neurosteroids shift partial agonist activation of GABAA recep- tor channels from low- to high- efﬁcacy gating patterns. J. Neurosci. 23, 10934–10943. Biggio, G., Concas, A., Follesa, P., Sanna, E., and Serra, M. (2007). Stress, ethanol, and neuroactive steroids. Pharmacol. Ther. 116, 140–171. Bitran, D., Shiekh, M., and McLeod, M. (1995). Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J. Neuroen- docrinol. 7, 171–177. Blaesse, P., Airaksinen, M. S., Rivera, C., and Kaila, K. (2009). Cation- chloride cotransporters and neu- ronal function. Neuron 61, 820–838. Bodnoff, S. R., Humphreys, A. G., Lehman, J. C., Diamond, D. M., Rose, G. M., and Meaney, M. J. (1995). Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hip- pocampal neuropathology in young and mid-aged rats. J. Neurosci. 15, 61–69. Bortolato, M., Devoto, P., Roncada, P., Frau, R., Flore, G., Saba, P., Pistritto, G., Soggiu, A., Pisanu, S., Zappala, A., Ristaldi, M. S., Tattoli, M., Cuomo, V., Marrosu, F., and Barbaccia, M. L. (2011). Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impair- ments. Neuropharmacology 60, 1301–1308. Boudaba, C., Szabo, K., and Tasker, J. G. (1996). Physiological mapping of local inhibitory inputs to the hypo- thalamic paraventricular nucleus. J. Neurosci. 16, 7151–7160. Boyd, K. N., Kumar, S., O’Buckley, T. K., Porcu, P., and Morrow, A. L. (2010). Ethanol induction of steroidogenesis in rat adrenal and brain is depen- dent upon pituitary ACTH release and de novo adrenal StAR synthesis. J. Neurochem. 112, 784–796. Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., and Wafford, K. A. (2002). Pharmacological character- ization of a novel cell line expressing human α4β3δ GABAA receptors. Br. J. Pharmacol. 136, 965–974. Brunton, P. J., McKay, A. J., Ochedal- ski, T., Piastowska, A., Rebas, E., Lachowicz, A., and Russell, J. A. (2009). Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone. J. Neurosci. 29, 6449–6460. Brunton, P. J., and Russell, J. A. (2008). The expectant brain: adapting for motherhood. Nat. Rev. Neurosci. 9, 11–25. Brunton, P. J., and Russell, J. A. (2010). Prenatal social stress in the rat programmes neuroendocrine and behavioural responses to stress in the adult offspring: sex-speciﬁc effects. J. Neuroendocrinol. 22, 258–271. Brunton, P. J., and Russell, J. A. (2011). Neuroendocrine control of maternal stress responses and fetal program- ming by stress in pregnancy. Prog. Neuropsychopharmacol. Biol. Psychi- atry 35, 1178–1191. Brussaard, A. B., Kits, K. S., Baker, R. E., Willems, W. P., Leyting-Vermeulen, J. W., Voorn, P., Smit, A. B., Bick- nell, R. J., and Herbison, A. E. (1997). Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABAA recep- tor subunit expression. Neuron 19, 1103–1114. Brussaard, A. B., and Koksma, J. J. (2003). Conditional regulation of neurosteroid sensitivity of GABAA receptors. Ann. N. Y. Acad. Sci. 1007, 29–36. Caldji, C., Diorio, J., and Meaney, M. J. (2003). Variations in maternal care alter GABAA receptor subunit expression in brain regions associ- ated with fear. Neuropsychopharma- cology 28, 1950–1959. Callachan, H., Cottrell, G. A., Hather, N. Y., Lambert, J. J., Nooney, J. M., and Peters, J. A. (1987). Mod- ulation of the GABAA receptor by progesterone metabolites. Proc. R. Soc. Lond. B Biol. Sci. 231, 359–369. Frontiers in Neuroscience | Neuroendocrine Science December 2011 | Volume 5 | Article 131 | 14